Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05677061
Other study ID # H-KF-298036
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2008
Est. completion date February 2023

Study information

Verified date February 2023
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluated whether HA coated dynamic hip screws can improve fixation of the screw in trochanteric femoral fractures


Description:

Randomised study to determine the effect of HA coating on the stability of dynamic Hip screws used to stabilize femoral neck fractures. Stability of the screw will be determined by RSA measurements. Additionally the fracture stability will be evaluated by RSA measurements.


Recruitment information / eligibility

Status Completed
Enrollment 37
Est. completion date February 2023
Est. primary completion date August 2013
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Patients with stable intertrochanteric femoral fractures (Evans I, II, IV) - able to speak Danish - able to complete the postoperative controls - written consent Exclusion Criteria: - unable to follow standard hip fracture regime - were breastfeeding - pregnant - terminal disease - in need of open fracture reduction - in need of DHS plate with an angle different from 135 degrees - insertion of fewer than 3 tantalum beads in the femoral head (for RSA) - TAD >20mm in two dimensions in the first postoperative x-ray - fracture displacement >20mm in two dimensions in the first postoperative x-ray

Study Design


Intervention

Device:
Dynamic Hip Screw with HA-coating (Hiploc)
During surgery for pertrochanteric hip fracture a lag screw with hydroxyapatite coating on the screw thread was used to fix the fracture
Dynamic Hip Screw without coating (Hiploc)
During surgery for pertrochanteric hip fracture a lag screw with no coating on the screw thread was used to fix the fracture

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
University of Aarhus Hospitalsenheden Vest, Hvidovre University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Lag Screw migration measured as y-translation (mm) Lag screw migration measured as y-translation (mm) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up 6 months PO
Secondary Lag screw migration measured as translations in mm Lag screw migration measured as translations in mm along the three orthogonal axes (x and z) and rotations in degrees about the three orthogonal axes (x, y and z) in addition to the summed translations (total translation) and summed rotations (total rotation) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up 6 months PO
Secondary Lag screw migration measured as rotations in degrees Lag screw migration measured as rotations in degrees about the three orthogonal axes (x, y and z) in addition to the summed summed rotations (total rotation) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up 6 months PO
Secondary Radiological measurements TAD AP+LAT, fracture reposition AP+LAT (mm) 6 months
Secondary Clinical outcomes - HHS Change in Harris Hip Score (HHS) measured as a scale from 0 (worst) to 100 (best) from pre-operative til 6 months postoperative 6 months PO
Secondary Clinical outcomes - NMS New Mobility Score measured on a scale from 0 (no mobility function) to 9 (full independent mobility function) preoperative Preoperative
Secondary Clinical outcomes - Leg Lengths difference Leg Length difference in cm at 6 months follow-up indicate fracture impaction 6 months
Secondary Clinical outcomes - TUG test Timed Up and Go Test (TUG) at 6 months follow-up (a score less than 20 seconds indicate mobility independence) 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05505604 - PENG vs FICB for Hip Fracture in ED Patients N/A
Enrolling by invitation NCT05094791 - Lateralization After IntraMedullary Nailing of InterTrochanteric Hip Fractures, Clinical and Radiographic Outcomes
Not yet recruiting NCT06078371 - Opioid-Free Pain Treatment in Trauma Patients N/A
Completed NCT04127045 - ProspEctive Cohort Study on Multidisciplinary Approach to Femur FRactures' manAgement in Over 65 Population
Completed NCT02294747 - Trochanteric Hip Fractures (AO A2) SHS With or Without Trochanteric Stabilizing Plate - Rct Using RSA N/A
Recruiting NCT05559736 - Artemis Proximal Femoral Nail for Internal Fixation of Intertrochanteric Femur Fractures N/A
Not yet recruiting NCT03911180 - Pertrochanteric Fracture Fixation In Elderly Adults Using Proximal Femoral Nail Anti-rotation (HERACLES) With a T-shaped Parallel Blade: A New Design N/A
Active, not recruiting NCT05197335 - Observational Clinical Study on Elderly Patients With Fracture of the Proximal Femur Treated With the Chimaera Nail
Recruiting NCT04470115 - Blocks for Intertrochanteric Fracture Repair Surgery N/A
Completed NCT03193697 - Efficacy and Safety of Cemented and Cementless Prostheses for Unstable Intertrochanteric Fractures in the Elderly N/A
Completed NCT04025866 - Addition of Aerobic Training to Conventional Rehabilitation After Femur Fracture N/A
Not yet recruiting NCT03407131 - Internal Fixation or Joint Replacement Therapy for Aged Hip Fracture Patients N/A
Completed NCT04229212 - Effectiveness of Using Closed-suction Drainage in Treating Proximal Femur Fracture With Cephalomedullary Nail N/A
Withdrawn NCT03955458 - EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture Phase 4
Completed NCT01344785 - The Effect of Loss of Offset After Pertrochanteric Fracture Treated With a Intramedullary Nail N/A
Completed NCT03182751 - Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement Phase 2
Completed NCT05359172 - The Effect of Tranexamic Acid in Total Blood Loss During Proximal Femoral Nailing